• President of Venture Leader Group

  • Former President of TEEC Angel Fund 

  • Executive Vice President of Technology and Research, Microsoft

Yeung Heung Yeung, PhD

  • Managing Director at Danforth Advisors with deep financial expertise

  • Investment Director at Jianxin Capital

Paul D. Rennert, PhD

Jin (Jim) Wang

Team

  • Immuno-oncology at Aleta, Biogen, and X-Rx

Management

Robert Perni, PhD

EXECUTIVE CHAIRMAN

Daniel Geffken, MBA

CORPORATE DEVELOPMENT, COO

WntRx's team is comprised of world-leading cancer researchers and biotech industry innovators whose work lies at the forefront of cancer therapeutics development. Management is guided by distinguished advisors, including industry leaders and highly experienced investors and entrepreneurs.

CO-FOUNDER, CBO (PART-TIME)
  • 20+ years of experience in founding, investing, and managing innovative therapeutic R&D companies

John Tagliamonte, MBA

  • 20+ years of experience in business development

  • ​Formerly at Johnson and Johnson, ImmunoGen, Anchor, and Oxyrane

  • Cancer biology at AnorMed and Genzyme

Simon Fricker, PhD

Advisors

  • Chemistry at Vertex Pharmaceuticals

CFO (PART-TIME)

Eric Cheng, MD, MBA